1. Home
  2. TVTX vs AGL Comparison

TVTX vs AGL Comparison

Compare TVTX & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • AGL
  • Stock Information
  • Founded
  • TVTX 2008
  • AGL 2016
  • Country
  • TVTX United States
  • AGL United States
  • Employees
  • TVTX N/A
  • AGL N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • AGL Managed Health Care
  • Sector
  • TVTX Health Care
  • AGL Health Care
  • Exchange
  • TVTX Nasdaq
  • AGL Nasdaq
  • Market Cap
  • TVTX 1.3B
  • AGL 1.4B
  • IPO Year
  • TVTX N/A
  • AGL 2021
  • Fundamental
  • Price
  • TVTX $14.92
  • AGL $4.00
  • Analyst Decision
  • TVTX Strong Buy
  • AGL Hold
  • Analyst Count
  • TVTX 13
  • AGL 19
  • Target Price
  • TVTX $33.75
  • AGL $4.28
  • AVG Volume (30 Days)
  • TVTX 2.0M
  • AGL 6.4M
  • Earning Date
  • TVTX 05-05-2025
  • AGL 05-06-2025
  • Dividend Yield
  • TVTX N/A
  • AGL N/A
  • EPS Growth
  • TVTX N/A
  • AGL N/A
  • EPS
  • TVTX N/A
  • AGL N/A
  • Revenue
  • TVTX $233,175,000.00
  • AGL $6,060,530,000.00
  • Revenue This Year
  • TVTX $68.31
  • AGL N/A
  • Revenue Next Year
  • TVTX $55.65
  • AGL $11.50
  • P/E Ratio
  • TVTX N/A
  • AGL N/A
  • Revenue Growth
  • TVTX 60.55
  • AGL 40.41
  • 52 Week Low
  • TVTX $5.12
  • AGL $1.50
  • 52 Week High
  • TVTX $25.29
  • AGL $7.73
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 37.07
  • AGL 41.56
  • Support Level
  • TVTX $14.13
  • AGL $5.35
  • Resistance Level
  • TVTX $15.23
  • AGL $5.64
  • Average True Range (ATR)
  • TVTX 1.31
  • AGL 0.49
  • MACD
  • TVTX -0.10
  • AGL -0.03
  • Stochastic Oscillator
  • TVTX 31.70
  • AGL 27.27

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About AGL agilon health inc.

Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

Share on Social Networks: